Global Anti-Obesity Drugs Market Professional Survey Report 2017

November 2017 | 110 pages | ID: GB6502C7F27EN
QYResearch

Abstracts

This report studies Anti-Obesity Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pfizer
• Merck
• F.Hoffmann-La Roche
• GlaxoSmithKline
• AstraZeneca
• Boehringer Ingelheim
• Novo Nordisk
• Eisai
• Norgine
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Vivus
• Alizyme
• Rhythm Pharmaceuticals
• Shionogi
• Zafgan

By types, the market can be split into

• Prescription Drugs
• OTC drugs

By Application, the market can be split into

• 6-18 Callant
• 18-30 Adult
• 30-60Middle-Aged
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Anti-Obesity Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF ANTI-OBESITY DRUGS

1.1 Definition and Specifications of Anti-Obesity Drugs
  1.1.1 Definition of Anti-Obesity Drugs
  1.1.2 Specifications of Anti-Obesity Drugs
1.2 Classification of Anti-Obesity Drugs
  1.2.1 Prescription Drugs
  1.2.2 OTC drugs
1.3 Applications of Anti-Obesity Drugs
  1.3.1 6-18 Callant
  1.3.2 18-30 Adult
  1.3.3 30-60Middle-Aged
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ANTI-OBESITY DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Anti-Obesity Drugs
2.3 Manufacturing Process Analysis of Anti-Obesity Drugs
2.4 Industry Chain Structure of Anti-Obesity Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ANTI-OBESITY DRUGS

3.1 Capacity and Commercial Production Date of Global Anti-Obesity Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Anti-Obesity Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Anti-Obesity Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Anti-Obesity Drugs Major Manufacturers in 2016

4 GLOBAL ANTI-OBESITY DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Anti-Obesity Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Anti-Obesity Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Anti-Obesity Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Anti-Obesity Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Anti-Obesity Drugs Sales Price
  4.4.2 2016 Anti-Obesity Drugs Sales Price Analysis (Company Segment)

5 ANTI-OBESITY DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Anti-Obesity Drugs Market Analysis
  5.1.1 North America Anti-Obesity Drugs Market Overview
  5.1.2 North America 2012-2017E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Anti-Obesity Drugs Sales Price Analysis
  5.1.4 North America 2016 Anti-Obesity Drugs Market Share Analysis
5.2 China Anti-Obesity Drugs Market Analysis
  5.2.1 China Anti-Obesity Drugs Market Overview
  5.2.2 China 2012-2017E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Anti-Obesity Drugs Sales Price Analysis
  5.2.4 China 2016 Anti-Obesity Drugs Market Share Analysis
5.3 Europe Anti-Obesity Drugs Market Analysis
  5.3.1 Europe Anti-Obesity Drugs Market Overview
  5.3.2 Europe 2012-2017E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Anti-Obesity Drugs Sales Price Analysis
  5.3.4 Europe 2016 Anti-Obesity Drugs Market Share Analysis
5.4 Southeast Asia Anti-Obesity Drugs Market Analysis
  5.4.1 Southeast Asia Anti-Obesity Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Anti-Obesity Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Anti-Obesity Drugs Market Share Analysis
5.5 Japan Anti-Obesity Drugs Market Analysis
  5.5.1 Japan Anti-Obesity Drugs Market Overview
  5.5.2 Japan 2012-2017E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Anti-Obesity Drugs Sales Price Analysis
  5.5.4 Japan 2016 Anti-Obesity Drugs Market Share Analysis
5.6 India Anti-Obesity Drugs Market Analysis
  5.6.1 India Anti-Obesity Drugs Market Overview
  5.6.2 India 2012-2017E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Anti-Obesity Drugs Sales Price Analysis
  5.6.4 India 2016 Anti-Obesity Drugs Market Share Analysis

6 GLOBAL 2012-2017E ANTI-OBESITY DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Anti-Obesity Drugs Sales by Type
6.2 Different Types of Anti-Obesity Drugs Product Interview Price Analysis
6.3 Different Types of Anti-Obesity Drugs Product Driving Factors Analysis
  6.3.1 Prescription Drugs of Anti-Obesity Drugs Growth Driving Factor Analysis
  6.3.2 OTC drugs of Anti-Obesity Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E ANTI-OBESITY DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Anti-Obesity Drugs Consumption by Application
7.2 Different Application of Anti-Obesity Drugs Product Interview Price Analysis
7.3 Different Application of Anti-Obesity Drugs Product Driving Factors Analysis
  7.3.1 6-18 Callant of Anti-Obesity Drugs Growth Driving Factor Analysis
  7.3.2 18-30 Adult of Anti-Obesity Drugs Growth Driving Factor Analysis
  7.3.3 30-60Middle-Aged of Anti-Obesity Drugs Growth Driving Factor Analysis
  7.3.4 Others of Anti-Obesity Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ANTI-OBESITY DRUGS

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Pfizer 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.2 Merck
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Merck 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Merck 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.3 F.Hoffmann-La Roche
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 F.Hoffmann-La Roche 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 F.Hoffmann-La Roche 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.4 GlaxoSmithKline
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 GlaxoSmithKline 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 GlaxoSmithKline 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.5 AstraZeneca
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 AstraZeneca 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 AstraZeneca 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.6 Boehringer Ingelheim
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Boehringer Ingelheim 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Boehringer Ingelheim 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.7 Novo Nordisk
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Novo Nordisk 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Novo Nordisk 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.8 Eisai
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Eisai 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Eisai 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.9 Norgine
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Norgine 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Norgine 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.10 Arena Pharmaceuticals
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Arena Pharmaceuticals 2016 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Arena Pharmaceuticals 2016 Anti-Obesity Drugs Business Region Distribution Analysis
8.11 Orexigen Therapeutics
8.12 Vivus
8.13 Alizyme
8.14 Rhythm Pharmaceuticals
8.15 Shionogi
8.16 Zafgan

9 DEVELOPMENT TREND OF ANALYSIS OF ANTI-OBESITY DRUGS MARKET

9.1 Global Anti-Obesity Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Anti-Obesity Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Anti-Obesity Drugs Sales Price Forecast
9.2 Anti-Obesity Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Anti-Obesity Drugs Consumption Forecast
  9.2.2 China 2017-2022 Anti-Obesity Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Anti-Obesity Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Anti-Obesity Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Anti-Obesity Drugs Consumption Forecast
  9.2.6 India 2017-2022 Anti-Obesity Drugs Consumption Forecast
9.3 Anti-Obesity Drugs Market Trend (Product Type)
9.4 Anti-Obesity Drugs Market Trend (Application)

10 ANTI-OBESITY DRUGS MARKETING TYPE ANALYSIS

10.1 Anti-Obesity Drugs Regional Marketing Type Analysis
10.2 Anti-Obesity Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Anti-Obesity Drugs by Region
10.4 Anti-Obesity Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ANTI-OBESITY DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ANTI-OBESITY DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-Obesity Drugs
Table Product Specifications of Anti-Obesity Drugs
Table Classification of Anti-Obesity Drugs
Figure Global Production Market Share of Anti-Obesity Drugs by Type in 2016
Figure Prescription Drugs Picture
Table Major Manufacturers of Prescription Drugs
Figure OTC drugs Picture
Table Major Manufacturers of OTC drugs
Table Applications of Anti-Obesity Drugs
Figure Global Consumption Volume Market Share of Anti-Obesity Drugs by Application in 2016
Figure 6-18 Callant Examples
Table Major Consumers of 6-18 Callant
Figure 18-30 Adult Examples
Table Major Consumers of 18-30 Adult
Figure 30-60Middle-Aged Examples
Table Major Consumers of 30-60Middle-Aged
Figure Others Examples
Table Major Consumers of Others
Figure Market Share of Anti-Obesity Drugs by Regions
Figure North America Anti-Obesity Drugs Market Size (Million USD) (2012-2022)
Figure China Anti-Obesity Drugs Market Size (Million USD) (2012-2022)
Figure Europe Anti-Obesity Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Anti-Obesity Drugs Market Size (Million USD) (2012-2022)
Figure Japan Anti-Obesity Drugs Market Size (Million USD) (2012-2022)
Figure India Anti-Obesity Drugs Market Size (Million USD) (2012-2022)
Table Anti-Obesity Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Anti-Obesity Drugs in 2016
Figure Manufacturing Process Analysis of Anti-Obesity Drugs
Figure Industry Chain Structure of Anti-Obesity Drugs
Table Capacity and Commercial Production Date of Global Anti-Obesity Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Anti-Obesity Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Anti-Obesity Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Anti-Obesity Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Anti-Obesity Drugs 2012-2017
Figure Global 2012-2017E Anti-Obesity Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Anti-Obesity Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Anti-Obesity Drugs Capacity and Growth Rate
Table 2016 Global Anti-Obesity Drugs Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Anti-Obesity Drugs Sales (K Units) and Growth Rate
Table 2016 Global Anti-Obesity Drugs Sales (K Units) List (Company Segment)
Table 2012-2017E Global Anti-Obesity Drugs Sales Price (USD/Unit)
Table 2016 Global Anti-Obesity Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Anti-Obesity Drugs 2012-2017E
Figure North America 2012-2017E Anti-Obesity Drugs Sales Price (USD/Unit)
Figure North America 2016 Anti-Obesity Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Anti-Obesity Drugs 2012-2017E
Figure China 2012-2017E Anti-Obesity Drugs Sales Price (USD/Unit)
Figure China 2016 Anti-Obesity Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Anti-Obesity Drugs 2012-2017E
Figure Europe 2012-2017E Anti-Obesity Drugs Sales Price (USD/Unit)
Figure Europe 2016 Anti-Obesity Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Anti-Obesity Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Anti-Obesity Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2016 Anti-Obesity Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Anti-Obesity Drugs 2012-2017E
Figure Japan 2012-2017E Anti-Obesity Drugs Sales Price (USD/Unit)
Figure Japan 2016 Anti-Obesity Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Anti-Obesity Drugs 2012-2017E
Figure India 2012-2017E Anti-Obesity Drugs Sales Price (USD/Unit)
Figure India 2016 Anti-Obesity Drugs Sales Market Share
Table Global 2012-2017E Anti-Obesity Drugs Sales (K Units) by Type
Table Different Types Anti-Obesity Drugs Product Interview Price
Table Global 2012-2017E Anti-Obesity Drugs Sales (K Units) by Application
Table Different Application Anti-Obesity Drugs Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Anti-Obesity Drugs Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck Anti-Obesity Drugs Business Region Distribution
Table F.Hoffmann-La Roche Information List
Table Product A Overview
Table Product B Overview
Table 2015 F.Hoffmann-La Roche Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 F.Hoffmann-La Roche Anti-Obesity Drugs Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GlaxoSmithKline Anti-Obesity Drugs Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZeneca Anti-Obesity Drugs Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2016 Boehringer Ingelheim Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Boehringer Ingelheim Anti-Obesity Drugs Business Region Distribution
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novo Nordisk Anti-Obesity Drugs Business Region Distribution
Table Eisai Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eisai Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eisai Anti-Obesity Drugs Business Region Distribution
Table Norgine Information List
Table Product A Overview
Table Product B Overview
Table 2016 Norgine Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Norgine Anti-Obesity Drugs Business Region Distribution
Table Arena Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Arena Pharmaceuticals Anti-Obesity Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Arena Pharmaceuticals Anti-Obesity Drugs Business Region Distribution
Table Orexigen Therapeutics Information List
Table Vivus Information List
Table Alizyme Information List
Table Rhythm Pharmaceuticals Information List
Table Shionogi Information List
Table Zafgan Information List
Figure Global 2017-2022 Anti-Obesity Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Anti-Obesity Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Anti-Obesity Drugs Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Anti-Obesity Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Anti-Obesity Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Anti-Obesity Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Anti-Obesity Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Anti-Obesity Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Anti-Obesity Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Anti-Obesity Drugs by Type 2017-2022
Table Global Consumption Volume (K Units) of Anti-Obesity Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Anti-Obesity Drugs by Region